Circulating tumor cells: quintessential precision oncology presenting challenges for biology

Código QR

Circulating tumor cells: quintessential precision oncology presenting challenges for biology

Guardado en:

Detalles Bibliográficos
Autor principal:	Rebecca J. Morris
Formato:	article
Lenguaje:	EN
Publicado:	Nature Portfolio 2017
Materias:	Neoplasms. Tumors. Oncology. Including cancer and carcinogens RC254-282
Acceso en línea:	https://doaj.org/article/e5113b110b7f478ca67b96d229f6f3d6
Etiquetas:	Agregar Etiqueta Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares

Structural variant detection in cancer genomes: computational challenges and perspectives for precision oncology
por: Ianthe A. E. M. van Belzen, et al.
Publicado: (2021)

Precision oncology- the future of personalized cancer medicine?
por: Ann M. Bode, et al.
Publicado: (2017)

Artificial intelligence for the next generation of precision oncology
por: Pedro J. Ballester, et al.
Publicado: (2021)

Network-based machine learning and graph theory algorithms for precision oncology
por: Wei Zhang, et al.
Publicado: (2017)

Live-single-cell phenotypic cancer biomarkers-future role in precision oncology?
por: Grannum R. Sant, et al.
Publicado: (2017)

Criteria-based curation of a therapy-focused compendium to support treatment recommendations in precision oncology
por: Frank P. Lin, et al.
Publicado: (2021)

A computational method for prioritizing targeted therapies in precision oncology: performance analysis in the SHIVA01 trial
por: Istvan Petak, et al.
Publicado: (2021)

Swiss-PO: a new tool to analyze the impact of mutations on protein three-dimensional structures for precision oncology
por: Fanny S. Krebs, et al.
Publicado: (2021)

Correction: Mechanisms of regulatory T cell infiltration in tumors: implications for innovative immune precision therapies
Publicado: (2021)

Case Reports in Oncology
Publicado: (2009)

Evaluation of disseminated tumor cells and circulating tumor cells in patients with breast cancer receiving adjuvant zoledronic acid
por: Neelima Vidula, et al.
Publicado: (2021)

The Prognostic Value of Circulating Tumor DNA in Ovarian Cancer: A Meta-Analysis
por: Yuanyuan Lu MD, et al.
Publicado: (2021)

Validation of a liquid biopsy assay with molecular and clinical profiling of circulating tumor DNA
por: Justin D. Finkle, et al.
Publicado: (2021)

Label-free isolation of prostate circulating tumor cells using Vortex microfluidic technology
por: Corinne Renier, et al.
Publicado: (2017)

Circulating tumor cell heterogeneity in neuroendocrine prostate cancer by single cell copy number analysis
por: Vincenza Conteduca, et al.
Publicado: (2021)

Single-cell RNA sequencing reveals spatial heterogeneity and immune evasion of circulating tumor cells
por: Yunfan Sun, et al.
Publicado: (2021)

Circulating tumor DNA and magnetic resonance imaging to predict neoadjuvant chemotherapy response and recurrence risk
por: Mark Jesus M. Magbanua, et al.
Publicado: (2021)

Circulating and disseminated tumor cells as a possible prognostic factor for oncological diseases
por: Andrei D. Kaprin, et al.
Publicado: (2021)

PD-L1 quantification across tumor types using the reverse phase protein microarray: implications for precision medicine
por: Mariaelena Pierobon, et al.
Publicado: (2021)

Circulating tumor cell number and endocrine therapy index in ER positive metastatic breast cancer patients
por: Costanza Paoletti, et al.
Publicado: (2021)

Author Correction: Circulating tumor cell heterogeneity in neuroendocrine prostate cancer by single cell copy number analysis
por: Vincenza Conteduca, et al.
Publicado: (2021)

Circulating tumor DNA dynamics in advanced breast cancer treated with CDK4/6 inhibition and endocrine therapy
por: Olga Martínez-Sáez, et al.
Publicado: (2021)

Circulating tumor cell copy-number heterogeneity in ALK-rearranged non-small-cell lung cancer resistant to ALK inhibitors
por: Marianne Oulhen, et al.
Publicado: (2021)

Discrete microfluidics for the isolation of circulating tumor cell subpopulations targeting fibroblast activation protein alpha and epithelial cell adhesion molecule
por: Małgorzata A. Witek, et al.
Publicado: (2017)

Precision medicine: the foundation of future cancer therapeutics
por: Seung Ho Shin, et al.
Publicado: (2017)

Circulating tumor DNA is readily detectable among Ghanaian breast cancer patients supporting non-invasive cancer genomic studies in Africa
por: Samuel Terkper Ahuno, et al.
Publicado: (2021)

Disease Free Survival in Breast Cancer Patients Who Receive Naturopathic Oncology Care
por: Leanna J. Standish ND, PhD, MSAOM, LAcup, FABNO
Publicado: (2021)

Next-generation sequencing of circulating tumor DNA to predict recurrence in triple-negative breast cancer patients with residual disease after neoadjuvant chemotherapy
por: Yu-Hsiang Chen, et al.
Publicado: (2017)

Precision cancer therapy is impacted by oncogene-dependent epigenome remodeling
por: Feng Liu, et al.
Publicado: (2017)

The tale of TILs in breast cancer: A report from The International Immuno-Oncology Biomarker Working Group
por: Khalid El Bairi, et al.
Publicado: (2021)

NRG Oncology/NSABP B-47 menstrual history study: impact of adjuvant chemotherapy with and without trastuzumab
por: Patricia A. Ganz, et al.
Publicado: (2021)

Precision cell-free DNA extraction for liquid biopsy by integrated microfluidics
por: Hoyoon Lee, et al.
Publicado: (2020)

Impact of C-reactive protein flare-response on oncological outcomes in patients with metastatic renal cell carcinoma treated with nivolumab
por: Toshiki Kijima, et al.
Publicado: (2021)

Need for specialized neuro-oncology units in low- and middle-income countries: Lessons learned from the COVID-19 pandemic
por: Jhoan Sebastián Robledo-Arias, et al.
Publicado: (2021)

Geriatric Oncology: From Research to Clinical Practice
por: Nienke A. de Glas
Publicado: (2021)

Correction: Impact of C-reactive protein flare-response on oncological outcomes in patients with metastatic renal cell carcinoma treated with nivolumab
Publicado: (2021)

Increasing Warmth in Oncological Patients: A Randomized Controlled Cross-Over Pilot Trial Examining the Efficacy of Mustard and Ginger Footbaths
por: Jan Vagedes MD, MA, et al.
Publicado: (2021)

Targeted biologic inhibition of both tumor cell-intrinsic and intercellular CLPTM1L/CRR9-mediated chemotherapeutic drug resistance
por: Deepak Parashar, et al.
Publicado: (2021)

Precision histology: how deep learning is poised to revitalize histomorphology for personalized cancer care
por: Ugljesa Djuric, et al.
Publicado: (2017)

Development and pilot of an online, personalized risk assessment tool for a breast cancer precision medicine trial
por: Holly Keane, et al.
Publicado: (2021)